Semaglutide is a synthetic medication engineered to mimic GLP-1's effects while remaining active for approximately 7 days, enabling practical once-weekly dosing
Tirzepatide: widely available with established access Tirzepatide is marketed as Mounjaro for type 2 diabetes and Zepbound for weight management
Antidiabetic drugs with controversial effects on cancer risk SGLT2 inhibitors The current body of research on the relationship between SGLT2 inhibitors and cancer risk remains inconclusive
38 These signs can include depression, ataxia, seizures, 47 behavioral changes, weakness, hyperesthesia, and trembling
Considerations for Safety Consulting Healthcare Providers : Before starting any new supplement regimen, especially for seniors with pre-existing health conditions or those taking medications, it is crucial to consult with a healthcare provider